Silent coronary artery disease in patients with type 2 diabetes mellitus

Acta Diabetologica

Volumn 40, Issue 4, 2003, Pages 176-180

  Gokcel, A ^a   Aydin, M ^a   Yalcin, F ^a   Yapar, A F ^a   Ertorer, M E ^a   Ozsahin, A K ^a   Muderrisoglu, H ^a   Aktas, A ^a   Guvener, N ^a   Akbaba, M ^b  

^a BASKENT UNIVERSITY   (Turkey)

^b CUKUROVA UNIVERSITY   (Turkey)

Author keywords

Myocardial scintigraphy; Silent coronary artery disease; SPECT; Tetrofosmin; Type 2 diabetes mellitus

Indexed keywords

DIPYRIDAMOLE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TETROFOSMIN TC 99M;

ADULT; AGE; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONFIDENCE INTERVAL; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; CORRELATION ANALYSIS; DIAGNOSTIC TEST; ELECTROCARDIOGRAM; EXERCISE TEST; FEMALE; GENDER; GLUCOSE BLOOD LEVEL; HEART PERFUSION; HEART SCINTISCANNING; HUMAN; HYPERTENSION; INJECTION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PREDICTION; PREVALENCE; PRIORITY JOURNAL; RETINOPATHY; SCREENING TEST; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ADULT; BLOOD GLUCOSE; BODY MASS INDEX; CORONARY DISEASE; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; FEMALE; HUMANS; LIPIDS; MALE; MIDDLE AGED; POSTPRANDIAL PERIOD; PREVALENCE; RISK FACTORS; TURKEY;

EID: 10744225117     PISSN: 09405429     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00592-003-0108-9     Document Type: Article

References (29)

1. Garcia MJ, McNamara PM, Gordon T, Kannell WB (1974) Morbidity and mortality in diabetics in the Framingham population. Sixteen year follow-up. Diabetes 23:105-111
2. Stamler J, Vaccaro O, Neaton JD, Wentworth D (1993) Diabetes, other risk factors, and 12-year cardiovascular mortality for men screened in the multiple risk factor intervention trial. Diabetes Care 16:434-444
3. Uusitupa MI, Niskanen LK, Siitonen O, Voutilainen E, Pyorala K (1993) Ten-year cardiovascular mortality in relation to risk factors and abnormalities in lipoprotein composition in type 2 (non-insulin-dependent) diabetic and non-diabetic subjects. Diabetologia 36:1175-1184
4. Gu K, Cowiee CC, Harris MI (1999) Diabetes and decline in heart disease mortality in US adults. JAMA 281:1291-1297
5. Haffner SM (2000) Coronary heart disease in patients with diabetes. N Engl J Med 342:1040-1042
6. Chiariello M, Indolfi C (1996) Silent myocardial ischemia in patients with diabetes mellitus. Circulation 93:2089-2091
7. Janand-Delenne B, Savin B, Habib G, Bory M, Vague P, Lassmann-Vague V (1999) Silent myocardial ischemia in patients with diabetes: who to screen. Diabetes Care 22:1396-1400
8. May O, Arildsen H, Damsgaard EM, Mickley H (1997) Prevalence and prediction of silent ischaemia in diabetes mellitus: a population based study. Cardiovasc Res 34:241-247
9. Inoguchi T, Yamashita T, Umeda F, Mihara H, Nakagaki O, Takada K, Kawano T, Murao H, Doi T, Nawata H (2000) High incidence of silent myocardial ischemia in elderly patients with non insulin-dependent diabetes mellitus. Diabetes Res Clin Pract 47:37-44
10. Koistinen MJ (1990) Prevalence of asymptomatic myocardial ischaemia in diabetic subjects. BMJ 301:92-95
11. Langer A, Freeman MR, Josse RG, Steiner G, Armstrong PW (1991) Detection of silent myocardial ischemia in diabetes mellitus. Am J Cardiol 67:1073-1078
12. Valensi P, Sachs RN, Lormeau B, Taupin JM, Ouzan J, Blasco A, Nitenberg A, Metz D, Paries J, Talvard O, Leutenegger M (1997) Silent myocardial ischaemia and left ventricle hypertrophy in diabetic patients. Diabet Metab 23:409-416
13. Milan Study on Atherosclerosis and Diabetes (MISAD) Group (1997) Prevalence of unrecognized silent myocardial ischemia and its association with atherosclerotic risk factors in non insulin-dependent diabetes mellitus. Am J Cardiol 134-139
14. Naka M, Hiramatsu K, Aizawa T, Momose A, Yoshizawa K, Shigematsu S, Ishihara F, Niwa A, Yamada T (1992) Silent myocardial ischemia in patients with non-insulin dependent diabetes mellitus as judged by treadmill exercise testing and angiography. Am Heart J 123:46-53
15. Nesto RW, Watson FS, Kowalchuk GJ, Zarich SW, Hill T, Lewis SM, Lane SE (1990) Silent myocardial ischemia and infarction in diabetics with peripheral vascular disease: assessment by dipyridamole thallium-201 scintigraphy. Am Heart J 120:1073-1077
16. Paillole C, Ruiz J, Juliard JM, Leblanc H, Gourgon R, Passa P (1995) Detection of coronary artery disease in diabetic patients. Diabetologia 38:726-731
17. Eichhom EJ, Kosinski EJ, Lewis SM, Hill TC, Emond LH, Leland OS (1988) Usefulness of dipyridamole-thallium-201 perfusion scanning for distinguishing ischemic from non-ischemic cardiomyopathy. Am J Cardiol 62:945-951
18. van Hoeven KH, Factor SM (1990) A comparison of the pathological spectrum of hypertensive, diabetic and hypertensive-diabetic heart disease. Circulation 82:848-855
19. Grossman E, Messerli FH (1996) Diabetic and hypertensive heart disease. Ann Intern Med 125:304-310
20. Sridhara B, Sochor H, Rigo P, Braat S, Itti R, Martinez-Duncker D, Cload P, Lahiri A (1994) Myocardial single-photon emission computed tomographic imaging with technetium99m tetrofosmin: stress-rest imaging with same-day rest imaging. J Nucl Cardiol 1:138-143
21. Danias PG, Ahlberg AW, Clark BA 3rd, Messineo F, Levine MG, McGill CC, Mann A, Clive J, Dougherty JE, Waters DD (1998) Combined assessment of myocardial perfusion and left ventricular function with exercise technetium-99m sestamibi gated single-photon emission computed tomography can differentiate between ischemic and nonischemic dilated cardiomyopathy. Am J Cardiol 82:1253-1258
22. Acampa W, Cuocolo A, Sullo P, Varrone A, Nicolai E, Pace L, Petretta M, Salvatore M (1998) Direct comparison of technetium 99m-sestamibi and technetium 99m-tetrofosmin cardiac single photon emission computed tomography in patients with coronary artery disease. J Nucl Cardiol 5:265-274
23. - (1999) Diabetes mellitus: a major risk factor for cardiovascular disease. Circulation 100:1132-1133 (editorial)
24. Grundy SM, Benjamin IJ, Burke GL, Chait A, Eckel RH, Howard BV, Mitch W, Smith SC Jr, Sowers JR (1999) Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation 100:1134-1146
25. Mazzone T (2000) Current concepts and controversies in the pathogenesis, prevention, and treatment of the macrovascular complications of diabetes. J Lab Clin Med 135:437-443
26. Miettinen H, Lehto S, Salomaa V, Mahonen M, Niemela M, Haffner SM, Pyorala K, Tuomilehto J (1998) Impact of diabetes on mortality after the first myocardial infarction. The FINMONICA Myocardial Infarction Register Study Group. Diabetes Care 21:69-75
27. Ahluwalia G, Jain P, Chugh SK, Wasir HS, Kaul U (1995) Silent myocardial ischemia in diabetics with normal autonomic function. Int J Cardiol 48:147-153
28. Nitenberg A, Valensi P, Sachs R, Dali M, Aptecar E, Attali JR (1993) Impairment of coronary vascular reserve and Ach-induced coronary vasodilation in diabetic patients with angiographically normal coronary arteries and normal left ventricular systolic function. Diabetes 42:1017-1025
29. Nesto RW (1999) Screening for asymptomatic coronary artery disease in diabetes. Diabetes Care 22:1393-1395